Literature DB >> 33332248

Implementation and evaluation of a novel, unofficial, trainee-organized hospital addiction medicine consultation service.

Thomas D Brothers1, John Fraser2, Emily MacAdam1, Brendan Morgan3, Jordan Francheville1, Aditya Nidumolu4, Christopher Cheung3, Samuel Hickcox5, David Saunders6,7, Tiffany O'Donnell8,9, Leah Genge2,6,9, Duncan Webster1,10.   

Abstract

Background: To evaluate a novel, unofficial, trainee-organized, hospital addiction medicine consultation service (AMCS), we aimed to assess whether it was (1) acceptable to hospital providers and patients, (2) feasible to organize and deliver, and (3) impacted patient care.
Methods: We performed a retrospective descriptive study of all AMCS consultations over the first 16 months. We determined acceptability via the number of referrals received from admitting services, and the proportion of referred patients who consented to consultation. We evaluated feasibility via continuation/growth of the service over time, and the proportion of referrals successfully completed before hospital discharge. As most referrals related to opioid use disorder, we determined impact through the proportion of eligible patients offered and initiated on opioid agonist therapy (OAT) in hospital, and the proportion of patients who filled their outpatient prescription or attended their first visit with their outpatient OAT prescriber.
Results: The unofficial AMCS grew to involve six hospital-based residents and five supervising community-based addiction physicians. The service received 59 referrals, primarily related to injection opioid use, for 50 unique patients from 12 different admitting services. 90% of patients were seen before discharge, and 98% agreed to addiction medicine consultation. Among 34 patients with active moderate-severe opioid use disorder who were not already on OAT, 82% initiated OAT in hospital and 89% of these patients continued after discharge. Conclusions: Established in response to identified gaps in patient care and learning opportunities, a novel, unofficial, trainee-organized AMCS was acceptable, feasible, and positively impacted patient care over the first 16 months. This trainee-organized, unofficial AMCS could be used as a model for other hospitals that do not yet have an official AMCS.

Entities:  

Keywords:  Inpatient; acute care; endocarditis; epidural abscess; substance use disorder

Mesh:

Year:  2020        PMID: 33332248     DOI: 10.1080/08897077.2020.1856291

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  9 in total

1.  Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.

Authors:  Thomas D Brothers; Dan Lewer; Nicola Jones; Samantha Colledge-Frisby; Michael Farrell; Matthew Hickman; Duncan Webster; Andrew Hayward; Louisa Degenhardt
Journal:  PLoS Med       Date:  2022-07-19       Impact factor: 11.613

2.  Linking opioid use disorder treatment from hospital to community.

Authors:  Thomas D Brothers; Dan Lewer; Ashish P Thakrar
Journal:  Addiction       Date:  2021-03-18       Impact factor: 7.256

3.  Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.

Authors:  Thomas D Brothers; Kimiko Mosseler; Susan Kirkland; Patti Melanson; Lisa Barrett; Duncan Webster
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

4.  Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.

Authors:  Susan L Calcaterra; Steve Lockhart; Catherine Callister; Kaitlyn Hoover; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2022-01-03       Impact factor: 6.473

5.  Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.

Authors:  Thomas D Brothers; Malcolm Leaman; Matthew Bonn; Dan Lewer; Jacqueline Atkinson; John Fraser; Amy Gillis; Michael Gniewek; Leisha Hawker; Heather Hayman; Peter Jorna; David Martell; Tiffany O'Donnell; Helen Rivers-Bowerman; Leah Genge
Journal:  Drug Alcohol Depend       Date:  2022-04-07       Impact factor: 4.852

6.  Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.

Authors:  Ghulam Karim Khan; Leah Harvey; Samantha Johnson; Paul Long; Simeon Kimmel; Cassandra Pierre; Mari-Lynn Drainoni
Journal:  Harm Reduct J       Date:  2022-04-12

7.  The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.

Authors:  Allison J Ober; Cristina Murray-Krezan; Kimberly Page; Peter D Friedmann; Karen Chan Osilla; Stephen Ryzewicz; Sergio Huerta; Mia W Mazer; Isabel Leamon; Gabrielle Messineo; Katherine E Watkins; Teryl Nuckols; Itai Danovitch
Journal:  Addict Sci Clin Pract       Date:  2022-07-28

8.  Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.

Authors:  Thomas D Brothers; John Fraser; Emily MacAdam; Brendan Morgan; Duncan Webster
Journal:  Drug Alcohol Rev       Date:  2021-08-04

9.  Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review.

Authors:  Thomas D Brothers; Dan Lewer; Matthew Bonn; Duncan Webster; Magdalena Harris
Journal:  BMJ Open       Date:  2021-08-09       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.